摘要
目的探讨分析温胆汤加减协同治疗精神分裂症的疗效及不良反应。方法将本院精神分裂症患者随机分为观察组与对照组。观察组采用温胆汤加减协同富马酸喹硫平片治疗,对照组单用富马酸喹硫平片治疗。结果观察组有效率为92%,对照组有效率为72%。两组治疗后第6周总分、阴性症状积分、阳性症状积分均较治疗前明显下降,观察组下降幅度高于对照组。观察组的药物不良反应发生率低于对照组。结论温胆汤加减协同治疗精神分裂症能够明显地减轻精神症状及降低精神药物的使用剂量。
Objective To discuss and analyze the clinical efficacy and adverse effects of Wendan decoction in collabo- rative treatment of schizophrenia. Methods Schizophrenia patients in our hospital were divided into observation group and control group randomly. The patients in observation group were treated with quetiapine fumarate tablets and Wen- dan decoction therapy, while the patients in control group were treated with quetiapine fumarate tablets alone. Results The effective rate of observation group was 92%, and control group was 72%. Compared with before treatment, after the sixth week treatment, the total score, negative symptoms score and positive symptoms score were decreased signifi- cantly, and observed group had larger decrease. The adverse drug reaction of observation group was lower than that of control group. Conclusion Wendan decoction collaborative treatment for schizophrenia can reduce psychiatric symp- toms and the use of psyehotropic drugs dose significantly.
出处
《中国当代医药》
2013年第3期112-113,共2页
China Modern Medicine
关键词
温胆汤
协同治疗
精神分裂症
喹硫平
Wendan decoction
Collaborative therapy
Schizophrenia
Quetiapine
